CAS号:133865-89-1
品名:沙芬酰胺(2S)-2-[[4-[(3-fluorophenyl)methoxy]phenyl]methylamino]propanamide
中文别名:(S)-2-[[4-[(3-氟苯甲基)氧]苯甲基]氨基]丙酰胺;
英文别名:(S)-2-[[4-[(3-Fluorobenzyl)oxy]benzyl]amino]propionamide;(S)-(+)-2-[4-(3-fluorobenzyloxy)benzylamino]-propanamide;(2S)-2-[4-(3-fluorobenzyloxy)benzylamino]propionamide;Safinamide;
分子式:C17H19FN2O2
分子量:302.343
精确质量:302.143
Psa:64.35
UNII号:90ENL74SIG
密度:1.189 g/cm3
沸点:476.7ºC at 760 mmHg
折射率:1.569
蒸汽压:2.98E-09mmHg at 25°C
简介:Safinamide(INN;brandnameXadago,formerdevelopmentalcodenameEMD-1195686)isadrugindicatedforthetreatmentofParkinson'sdiseasewithmultiplemethodsofaction.In2007,aPhaseIIIclinicaltrialwasstarted.Itwasscheduledtorununtil2011.ThecompoundwasoriginallydiscoveredatFarmitalia-CarloErba,firstpublishedin1998anddevelopedbyNewronPharmaceuticals,whichsoldtherightstoMerck-Seronoin2006.InOctober2011Merck-SeronoannouncedthattheywouldgiveallrightstodevelopthecompoundbacktoNewron.
膜转运/离子通道